Showing results (101-110 of 140) with videos related to

Sort By:
Pageof 14
American Heart Journal|February 15, 2011
Incidence and clinical consequences of acquired thrombocytopenia after antithrombotic therapies in patients with acute coronary syndromes: results from the Acute Catheterization and Urgent Intervention Triage Strategy (ACUITY) trialAdriano Caixeta, George D Dangas, Roxana Mehran, et al.
Journal of the American College of Cardiology|July 19, 2005
The effect of variable dose and release kinetics on neointimal hyperplasia using a novel paclitaxel-eluting stent platform: the Paclitaxel In-Stent Controlled Elution Study (PISCES)Patrick W Serruys, Georgios Sianos, Alexandre Abizaid, et al.
Cardiovascular Radiation Medicine|October 22, 2005
No change in endothelial-dependent vasomotion late after coronary irradiationSjoerd H Hofma, Bas M van Dalen, Pedro A Lemos, et al.
Journal of the American College of Cardiology|May 17, 2005
Endothelial progenitor cell capture by stents coated with antibody against CD34: the HEALING-FIM (Healthy Endothelial Accelerated Lining Inhibits Neointimal Growth-First In Man) RegistryJiro Aoki, Patrick W Serruys, Heleen van Beusekom, et al.
Cardiovascular Intervention and Therapeutics|April 24, 2013
Angiographic findings of everolimus-eluting as compared to sirolimus-eluting stents: angiographic sub-study from the Randomized Evaluation of Sirolimus-eluting versus Everolimus-eluting stent Trial (RESET)Ken Kozuma, Takeshi Kimura, Kazushige Kadota, et al.
European Heart Journal|April 30, 2005
Five year clinical effect of coronary stenting and coronary artery bypass grafting in renal insufficient patients with multivessel coronary artery disease: insights from ARTS trialJiro Aoki, Andrew T L Ong, Angela Hoye, et al.
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|September 18, 2009
One-year clinical outcome of various doses and pharmacokinetic release formulations of paclitaxel eluted from an erodable polymer - Insight in the Paclitaxel In-Stent Controlled Elution Study (PISCES)Jiro Aoki, Andrew T L Ong, Alexandre Abizaid, et al.
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|September 18, 2009
Drug-eluting stent implantation for chronic total occlusions: comparison between the Sirolimus- and Paclitaxel-eluting stentAngela Hoye, Andrew T L Ong, Jiro Aoki, et al.
Journal of Cardiology|June 5, 2021
The role of the renal resistance index in patients with heart failure with reduced or preserved ejection fractionDaijiro Tomii, Yu Horiuchi, Yuki Gonda, et al.
The American Journal of Cardiology|December 26, 2007
Clinical outcomes after heterogeneous overlap stenting with drug-eluting stents and bare-metal stents for de novo coronary artery narrowingsJiro Aoki, Ajay J Kirtane, George D Dangas, et al.
Pageof 14